{"id":"W2922151066","doi":"10.1007/s40744-019-0149-3","title":"Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry","year":2019,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Momenta Pharmaceuticals; Valeant Pharmaceuticals International; Regeneron Pharmaceuticals; Genentech; Horizon Pharma; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Internal medicine; Rheumatoid arthritis; Cohort; Etanercept; Propensity score matching; Rheumatology; Serostatus; Rheumatoid factor; Oncology; Physical therapy; Immunology; Rituximab; Human immunodeficiency virus (HIV)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001733268,0.0001797837,0.0006719294,0.0004625959,0.0002019645,0.0005285331,0.0004613758,0.0003436192,0.001274174],"category_scores_gemma":[0.003751954,0.0002052038,0.001306387,0.0007131806,0.0002526683,0.0003015518,0.0003124946,0.0003348016,0.0002104077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007224838,"about_ca_system_score_gemma":0.0008986626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003480691,"about_ca_topic_score_gemma":0.006006109,"domain_scores_codex":[0.9977971,0.0009659186,0.0003199592,0.0004867966,0.0002884994,0.0001417897],"domain_scores_gemma":[0.997012,0.0009120899,0.001398804,0.0002356627,0.0001708393,0.0002706811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03650114,0.0005683076,0.9388066,0.000495393,0.003553512,0.0001300454,0.0001123398,0.0006533696,0.0007018034,0.0001265562,0.001178622,0.01717237],"study_design_scores_gemma":[0.006601006,0.009255964,0.975047,0.0001637631,0.003804152,0.0005936332,0.0002325178,0.001540968,0.0005189853,0.0001245797,0.002087247,0.0000301802],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954834,0.002051815,0.0001373372,0.00006373577,0.00002328479,0.00007612287,0.001515391,0.000005512603,0.0006434559],"genre_scores_gemma":[0.9977533,0.0005637327,0.0001414206,0.00008597782,0.00002935328,0.00007093627,0.001242782,0.000002702556,0.000109715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003480691,"threshold_uncertainty_score":0.009166539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01080818675483732,"score_gpt":0.2590551601920899,"score_spread":0.2482469734372526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}